BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 25151951)

  • 21. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
    Markou A; Sertedaki A; Kaltsas G; Androulakis II; Marakaki C; Pappa T; Gouli A; Papanastasiou L; Fountoulakis S; Zacharoulis A; Karavidas A; Ragkou D; Charmandari E; Chrousos GP; Piaditis GP
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2857-64. PubMed ID: 25974737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
    J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series.
    Fallo F; Castellano I; Gomez-Sanchez CE; Rhayem Y; Pilon C; Vicennati V; Santini D; Maffeis V; Fassina A; Mulatero P; Beuschlein F; Reincke M
    Endocrine; 2017 Dec; 58(3):503-512. PubMed ID: 28405879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotype-genotype correlation in aldosterone-producing adenomas characterized by intracellular cholesterol metabolism.
    Harashima S; Yamazaki Y; Motomura N; Ono Y; Omata K; Tezuka Y; Morimoto R; Nakamura Y; Satoh F; Suzuki H; Kwon GE; Choi MH; Sasano H
    J Steroid Biochem Mol Biol; 2022 Jul; 221():106116. PubMed ID: 35533918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PCP4: a regulator of aldosterone synthesis in human adrenocortical tissues.
    Felizola SJ; Nakamura Y; Ono Y; Kitamura K; Kikuchi K; Onodera Y; Ise K; Takase K; Sugawara A; Hattangady N; Rainey WE; Satoh F; Sasano H
    J Mol Endocrinol; 2014 Apr; 52(2):159-67. PubMed ID: 24403568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone-Producing Adenomas: Histopathology-Genotype Correlation and Identification of a Novel
    Tan GC; Negro G; Pinggera A; Tizen Laim NMS; Mohamed Rose I; Ceral J; Ryska A; Chin LK; Kamaruddin NA; Mohd Mokhtar N; A Jamal AR; Sukor N; Solar M; Striessnig J; Brown MJ; Azizan EA
    Hypertension; 2017 Jul; 70(1):129-136. PubMed ID: 28584016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Translationality of
    Kitamoto T; Nishikawa T
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disordered CYP11B2 Expression in Primary Aldosteronism.
    Gomez-Sanchez CE; Kuppusamy M; Reincke M; Williams TA
    Horm Metab Res; 2017 Dec; 49(12):957-962. PubMed ID: 29202495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma.
    Oki K; Gomez-Sanchez CE
    Endocr J; 2020 Oct; 67(10):989-995. PubMed ID: 32968034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
    Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
    J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations.
    Fernandes-Rosa FL; Amar L; Tissier F; Bertherat J; Meatchi T; Zennaro MC; Boulkroun S
    Mol Cell Endocrinol; 2015 Jun; 408():220-6. PubMed ID: 25617716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on novel mechanisms of primary aldosteronism.
    Zennaro MC; Boulkroun S; Fernandes-Rosa F
    J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visualization of calcium channel blockers in human adrenal tissues and their possible effects on steroidogenesis in the patients with primary aldosteronism (PA).
    Motomura N; Yamazaki Y; Gao X; Tezuka Y; Omata K; Ono Y; Morimoto R; Satoh F; Nakamura Y; Shim J; Choi MH; Ito A; Sasano H
    J Steroid Biochem Mol Biol; 2022 Apr; 218():106062. PubMed ID: 35031428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and functional role of urotensin-II and its receptor in the adrenal cortex and medulla: novel insights for the pathophysiology of primary aldosteronism.
    Giuliani L; Lenzini L; Antonello M; Aldighieri E; Belloni AS; Fassina A; Gomez-Sanchez C; Rossi GP
    J Clin Endocrinol Metab; 2009 Feb; 94(2):684-90. PubMed ID: 19001524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
    Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y
    Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metallothionein-3 (MT-3) in the human adrenal cortex and its disorders.
    Felizola SJ; Nakamura Y; Arata Y; Ise K; Satoh F; Rainey WE; Midorikawa S; Suzuki S; Sasano H
    Endocr Pathol; 2014 Sep; 25(3):229-35. PubMed ID: 24242700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands.
    Nishimoto K; Tomlins SA; Kuick R; Cani AK; Giordano TJ; Hovelson DH; Liu CJ; Sanjanwala AR; Edwards MA; Gomez-Sanchez CE; Nanba K; Rainey WE
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):E4591-9. PubMed ID: 26240369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations.
    Nanba K; Omata K; Tomlins SA; Giordano TJ; Hammer GD; Rainey WE; Else T
    Eur J Endocrinol; 2016 Aug; 175(2):K1-6. PubMed ID: 27165862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
    Gomez-Sanchez CE; Oki K
    Endocrinology; 2014 Jan; 155(1):47-55. PubMed ID: 24248457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.